In the assessment of osteoporosis, why is screening for secondary causes important?

Study for the Medical Council of Canada Qualifying Examination (MCCQE) I. Engage with flashcards and multiple-choice questions with detailed feedback. Prepare confidently!

Multiple Choice

In the assessment of osteoporosis, why is screening for secondary causes important?

Screening for secondary causes matters because osteoporosis is not always due to aging alone; many conditions and drugs can drive bone loss and are potentially reversible with proper treatment. Identifying a secondary cause lets you treat the underlying problem—such as hyperparathyroidism, thyroid disease, Cushing syndrome, vitamin D deficiency, or medication effects like glucocorticoids—and often slows or reverses bone loss, thereby reducing fracture risk. It also guides the choice and intensity of osteoporosis-directed therapy, since addressing the root cause can change how you approach prevention and treatment. Without screening, a treatable contributor to bone loss might be missed, leaving fracture risk inadequately addressed.

Screening for secondary causes matters because osteoporosis is not always due to aging alone; many conditions and drugs can drive bone loss and are potentially reversible with proper treatment. Identifying a secondary cause lets you treat the underlying problem—such as hyperparathyroidism, thyroid disease, Cushing syndrome, vitamin D deficiency, or medication effects like glucocorticoids—and often slows or reverses bone loss, thereby reducing fracture risk. It also guides the choice and intensity of osteoporosis-directed therapy, since addressing the root cause can change how you approach prevention and treatment. Without screening, a treatable contributor to bone loss might be missed, leaving fracture risk inadequately addressed.

More practice questions